Mark Wilkinson
University of Sheffield · National Advanced Driving Simulator
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Mark Wilkinson as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 02:37 UTC. Open this list on ClinicalTrials.gov
- Ph4NCT01293292 · Teriparatide (Forsteo) Treatment in Postmenopausal Women: Mechanism of ActionSheffield Teaching Hospitals NHS Foundation Trust · completed · Osteoporosis · principal investigator
- N/ANCT00581659 · Evaluation of the Bausch & Lomb PureVision Under Nighttime Driving ConditionsUniversity of Iowa · completed · Astigmatism · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 02:37 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 02:37 UTC. The ranking covers the 200 most relevant of 77 PubMed records, and a shared surname and initials can bring in a namesake. All 77 on PubMed
- Ten-Hour Time-Restricted Eating Reduces Weight, Blood Pressure, and Atherogenic Lipids in Patients with Metabolic Syndrome.Cell Metab · 2020724 citationsRCR 37.1
- Risk factors for complication following ERCP; results of a large-scale, prospective multicenter study.Endoscopy · 2007298 citationsRCR 11.0
- The interaction of fentanyl on the Cp50 of propofol for loss of consciousness and skin incision.Anesthesiology · 1994281 citationsRCR 12.8
- Circulating tumor cells: a useful predictor of treatment efficacy in metastatic breast cancer.J Clin Oncol · 2009253 citationsRCR 5.3
- 153 citationsRCR 5.2
- 130 citationsRCR 4.7
- Durable efficacy of enfuvirtide over 48 weeks in heavily treatment-experienced HIV-1-infected patients in the T-20 versus optimized background regimen only 1 and 2 clinical trials.J Acquir Immune Defic Syndr · 2005128 citationsRCR 3.2
- Lorundrostat Efficacy and Safety in Patients with Uncontrolled Hypertension.N Engl J Med · 2025119 citationsRCR 36.4
- The radioisotope contributes significantly to the activity of radioimmunotherapy.Clin Cancer Res · 2004109 citationsRCR 2.6
- Effects of a 2- to 4-week course of repetitive transcranial magnetic stimulation (rTMS) on neuropsychologic functioning, electroencephalogram, and auditory threshold in depressed patients.Biol Psychiatry · 200195 citationsRCR 3.1